Everyone can see how the shelf space in the big Canadian grocery chains has been growing significantly for organic. This company is a distributor for organic brands, both into those grocery stores, and also into Starbucks (SBUX-Q). Thinks there is significant, significant upside, and has this pegged at something like 140% revenue growth next year. (Analysts’ price target is $2.08.)
They made two recent acquisitions and have good relationships with purchases at L-T and EMP-T. He thinks their shelf space will continue and grow.
They are trying to consolidate the organic food industry. He likes the management team. He likes the strategy. They needed to get bigger. They can now move forward with cash flow growth.
Likes this company. The stock has started to perform well. Recently acquired Central Roast. They are in the right space at the right time. Recently did a financing, and thinks there is some difficulty in getting it completed. Very close to being breakeven now.
Acquiring Central Roast which has a lot of organic type products that they are getting into Canadian grocery stores, a real growth market. Management has a deep relationship with some of the big grocery chains in Canada. Thinks they are going to grow something like over 100% next year with this acquisition. On top of that there is north of 60% organic growth.
Acquiring Central Roast which has a lot of organic type products that they are getting into Canadian grocery stores, a real growth market. Management has a deep relationship with some of the big grocery chains in Canada. Thinks they are going to grow something like over 100% next year with this acquisition. On top of that there is north of 60% organic growth.
Everyone can see how the shelf space in the big Canadian grocery chains has been growing significantly for organic. This company is a distributor for organic brands, both into those grocery stores, and also into Starbucks (SBUX-Q). Thinks there is significant, significant upside, and has this pegged at something like 140% revenue growth next year. (Analysts’ price target is $2.08.)